This document provides an overview of ankylosing spondylitis and related spondyloarthropathies. It discusses the definition, epidemiology, etiology, pathological anatomy, clinical manifestations, diagnostic criteria and evaluation, and treatment of these conditions. Key points include that ankylosing spondylitis is a chronic inflammatory disease associated with the HLA-B27 gene, it predominantly affects the spine and sacroiliac joints, and diagnosis involves assessing symptoms of inflammatory back pain and structural damage visible on imaging studies according to criteria from ASAS.
hip osteoarthritis is most disabling condition and surgery is a consequence of the same. but if this condition can assess on time so it can be manageable with conservative treatment and decrease the prevalence of AVN. further life of an individual become better.
Evidence Based Practice in Medical Imaging- Ankylosing SpondylitisNoor Farahuda
This presentation is about evidence-based practice in medical imaging for a particular disease, which is the Ankylosing Spondylitis. It is actually focusing on the imaging modalities that have been used for diagnose the disease and the appearances of the disease on the image of the modalities.
the presentation gives a detail information about the seronegative spondyloarthropathy. this ppt also provide recent evidences to frame the rehab protocol.
Abhijeet Danve, MD, FACP, FACR, prepared useful Practice Aids pertaining to axial spondyloarthritis for this CME activity titled “Overcoming Challenges in the Diagnosis and Management of Axial Spondyloarthritis: New Insights and Implications for Clinical Practice.” For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at https://bit.ly/2A6Xi8d. CME credit will be available until August 27, 2021.
hip osteoarthritis is most disabling condition and surgery is a consequence of the same. but if this condition can assess on time so it can be manageable with conservative treatment and decrease the prevalence of AVN. further life of an individual become better.
Evidence Based Practice in Medical Imaging- Ankylosing SpondylitisNoor Farahuda
This presentation is about evidence-based practice in medical imaging for a particular disease, which is the Ankylosing Spondylitis. It is actually focusing on the imaging modalities that have been used for diagnose the disease and the appearances of the disease on the image of the modalities.
the presentation gives a detail information about the seronegative spondyloarthropathy. this ppt also provide recent evidences to frame the rehab protocol.
Abhijeet Danve, MD, FACP, FACR, prepared useful Practice Aids pertaining to axial spondyloarthritis for this CME activity titled “Overcoming Challenges in the Diagnosis and Management of Axial Spondyloarthritis: New Insights and Implications for Clinical Practice.” For the full presentation, monograph, complete CME information, and to apply for credit, please visit us at https://bit.ly/2A6Xi8d. CME credit will be available until August 27, 2021.
Chlamydia-induced Reactive Arthritis research project. Discusses pathogenesis, symptoms, and etiology. Summarizes possible treatment plans and includes questions for further research.
TREATMENT OF RHEUMATOID ARTHRITIS BY DR BASHIR AHMED DAR ASSOCIATE PROFESSOR ...Prof Dr Bashir Ahmed Dar
Dr Bashir ahmed dar associate professor medicine chinkipora sopore kashmir presently working in medical college malaysia describes rheumatoid arthritis which is a autoimmune disorder in which Immune system identifies the synovial membrane as "foreign" and begins attacking it.
All about Spondyloarthropaties also known as Seronegative Arthritis in a nutshell....includes Pathology,signs and symptoms, investigations, and latest approved treatment of all subtypes....compiled from Turek and Harrisons textbook.
For More Medicine Free PPT - http://playnever.blogspot.com/
For Health benefits and medicine videos Subscribe youtube channel - https://www.youtube.com/playlist?list=PLKg-H-sMh9G01zEg4YpndngXODW2bq92w
Guía de práctica clínica para el diagnóstico y el tratamiento de las infecciones bacterianas y micóticas en pacientes oncológicos mayores de 15 años con neutropenia febril posquimioterapia de alto riesgo. Rev Colomb Cancerol. 2014;18(4):186---196
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America Alison G. Freifeld,1 Eric J. Bow,9 Kent A. Sepkowitz,2 Michael J. Boeckh,4 James I. Ito,5 Craig A. Mullen,3 Issam I. Raad,6 Kenneth V. Rolston,6 Jo-Anne H. Young,7 and John R. Wingard8, 2010, Revisada en 2013
Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Annals of Oncology Volume 21, Issue suppl 5 J. de Naurois 1, I. Novitzky-Basso 2, MJ Gill 3, F. Martí Martí 1, MH Cullen 1, F. Roila 4
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
2. Ankylosing spondylitis
Reiter's syndrome (reactive or arthritis)
Arthropathy of inflammatory bowel disease (Crohn's disease, ulcerative
colitis)
Psoriatic arthritis
Undifferentiated spondyloarthropathies
Juvenile chronic arthritis and ankylosing spondylitis of juvenile onset
Spondyloarthropathies
3. Angkylos and spondylos
Is a chronic inflammatory disease associated with the
human leukocyte antigen (HLA-B27)
Extra-articular Manifestations
DEFINITION
4. In 1666-1698 Bernard Corner
By Waters :
1693- 1824
1824 -1885
1897 -1931
1936 - 1950
In 1850, Brodie
In 1896, Roentgen had discovered the radiographic technique; but 1930
History
5. BEFORE Y AFTER 1950
LUMPERS SPLITTERS
1963 SAR
SA- ES-AP, SR
NOT KNOWN ETIOLOGY
History
6. 1968 BERNAR AMOR SPA- S. REITER , COMMON GENETIC BASIS
1970: spondyloarthropathy
Moll et al: seronegative spondyloarthropathy
History
7.
8. Servicio de Rhumatologie,
universitaire hopital Reina
Sofía, departamento de
Médecine, Université de
Cordoue, Córdoba, España.
Joint Bone Spine (factor de
impacto: 2,75). 02/2000; 67 (6):
516-20.Fuente: PubMed
Recomendación 12. No se recomiendan los criterios de ESSG ni los de
Amor para la clasificación de las EsA [2b, B, 74,3%].
10. Predisposition in certain population groups, such as American Indians or
tribes near the Arctic
Europe 0.3 or 1.8% of the population
In Japan 0.3 to 6.9 in Finland and 7.3 in USA per people 100,000 / year
Mexico is 0.9% among general
Caucasian 0.05%
prevalence of HLA-B27, around 2.5%
Epidemiology
11. Males (3 to 5 times more)
Onset after 50 years is exceptional
Epidemilogy
17. FOLDING INSUFFICIENT HLA B-27
Formation of a misfolded form of HLA-B27 within the endoplasmic reticulum
of an antigen-presenting cell and the elicitation of stress and
proinflammatory responses
ETIOLOGY
18. Homodimers on the cell surface and noncanonical recognition of HLA-B27
Generation of additional forms of HLA-B27, such as free heavy chains and
dimers on the cell surface, and their interactions with T cells, natural killer
cells and antigen-presenting cells.
ETIOLOGY
19. - L T CD8 AND PRESENTATION OF THE SURFACE ANTIGENS OF HLA B27
A DECREASEDTHE AMOUNT DUE EXPLANATION OF
PATHOPHYSIOLOGY A NEW KNOWLEDGE
- ANY OTHERTHEORY EXCLUDES AND CAN NOT EVEN
EXPLAINTHE PATHOGENESIS
Conclusions
27. Clinical history as a screening test for ankylosing spondylitis
A controlled study of 138 subjects demonstrated that the clinical history may be sensitive (95%)
and specific (85%) in the differential diagnosis of ankylosing spondylitis when reliance of five
specific historic features is made. Back pain that is insidious in onset, in a patient younger than
40 years, persisting for at least three months, associated with morning stiffness and improving
with exercise is characteristic of inflammatory spinal disease
INFLAMMATORY BACK PAIN
28. Inflammatory back pain in ankylosing spondylitis: a reassessment of the
clinical history for application as classification and diagnostic criteria
We assessed the clinical history of 213 patients (101 with AS and 112 with MLBP)
younger than 50 years who had chronic back pain. Single clinical parameters and
combinations of parameters were compared between the AS and MLBP patient
groups.
ASAS IBP criteria mnemonic for criteria “Ipain
S: 77% E 91.7%
CB: > E < S
CC: > S < E
Ozgocmen S, Akgul O, Khan MA. Mnemotécnico para la evaluación de los
criterios de la sociedad internacional espondiloartritis. J Rheumatol. 2010; 37 :.
1978
CRITERIA BERLIN
69. DIAGNOSIS . CRITERIA ASAS
M Rudwaleit1 D van der Heijde2 R Landewé3 N Akkoc4 J Brandt5 C T Chou6 M Dougados7 F Huang8 J Gu9 Y Kirazli10 F Van
den Bosch11 I Olivieri12 E Roussou13 S Scarpato14 I J Sørensen15 R Valle-Oñate16 U Weber17 J Wei18 J Sieper
70.
71. Area Domain Measurement / Instrument
ACTIVITY
(General and nightly)
spinal pain Horizontal
scale with numerical descriptors (1-10)
Patient global assessment Horizontal scale with numerical descriptors (1-10)
BASDAI
Overall rating of health Horizontal scale with numerical descriptors (1-10)
fatigue Horizontal scale with numerical descriptors (1-10)
joint count Count of 44, 78/76 or 68/66 or 28 joints
enthesitis Validated index (MASES, San Francisco, Berlin, etc)
dactylitis Present / absent and acute / chronic
Acute phase reactants ESR,CRP
spinal Stiffness Horizontal scale with numerical descriptors (1-10)
72. Area Domain Measurement / Instrument
Function
spinal mobility chest expansion
Test Schöber
Occiput-wall distance
cervical rotation
Lateral flexion of the spine
BASMI
General
function
BASFI
HAQ
structural Damage X-ray
Based on the criteria of NewYork Scale
(sacroiliac joints)
mSASSS (column) or BASRI (spine and hip)
ASspiMRI
79. ACTIVITY CRITERIA AND REFERRAL
ASDAS
Lukas et al. Ann RheumDis 2009;68:18-24
van derHeiijdeD et al. Ann Rheum Dis. 2008 Dec 5. [Epubahead of print]
80. ASDAS
Lukas et al. Ann RheumDis 2009;68:18-24
van derHeiijdeD et al. Ann Rheum Dis. 2008 Dec 5. [Epubahead of print]
97. 1. FRONTLINE
NSAIDS
COX-2 INHIBITORS
2. SECOND LINE
METHOTREXATE: NO EVIDENCE
STEROIDS
SULFASALAZINE
3. BIOLOGICAL:
TNF INHIBITORS
4. ALTERNATIVETHERAPIES
ABATACEPT INHIBITINGT CELL COSTIMULATION (CTLA-4Ig)
THE IL-1 RECEPTOR ANTAGONIST ANAKINRA HAS BEEN STUDIED IN PATIENTS
WITH AS
APREMILAST IS A PHOSPHODIESTERASE-4
TALIDOMIDA INHIBITING DE FNT
RITUXIMAB INHIBITING C20
TOCILIZUMAB MONOCLONAL ANTIBODY DESIGNEDTO INHIBIT BOTH SIGNALS
THROUGHTHE MEMBRANE AND SOLUBLE IL-6R
TREATMENT
98. EFFICIENCY SHORT
AND LONG TERM
INFLIXIMAB
5 mg/kg 0-2-6 y 8
RESPONSE VARIABLE
37-67%
ADALIMUMAB
40 mg c/ 2 s
ASAS 40
IMPROVEMENT
CRITERIA OF 54% VS
12.5 PLACEBO GROUP
ETANERCEP
25 MG SC 2 V X S
BASDAI 66.1%
IMPROVEMENT IN
RELATION TO
PLACEBO GROUP 50%
GOLIMUMAB
50-100 mg 1 v/ moth
IMPROVEMENT
CRITERIA ASAS 40% IN
RELATION TO 12% OF
PLACEBO
BIOLOGICAL: TNF INHIBITORS
99. A historical perspective of the spondyloarthritis
Henning Zeidlera, Andrei Calinb and Bernard Amorc
Current Opinion in Rheumatology 2011, 23:327–333
Hospital Clinicoquirúrgico Intermunicipal "Mártires del 9 de Abril
«www.ncbi.nlm.nih.gov/pubmed/21519270
PATOGENIA DE LAS ESPONDILOARTROPATÍAS SERONEGATIVAS
Dr. Modesto González Cortiñas
Rev Cubana Med 1998;37(1):28-35
Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis
Matthew A. Brown, MB, BS, MD, FRACP, Alison M. Crane, PhD, and B. Paul Wordsworth, MRCP
Current Opinion in Rheumatology 2002, 14:354–360
Pathogenesis of ankylosing spondylitis and reactive arthritis
Tae-Hwan Kima, Wan-Sik Uhma and Robert D. Inman Curr Opin Rheumatol 17:400—405. ª 2005
Lippincott Williams & Wilkins.
Classification criteria for spondyloarthropathies Published online: December 18, 2012.
www.wjgnet.com
REFERENCES
100. http://www.asas-group.org/mission-statement.php
http://www.ser.es/practicaClinica/espoguia/espondilitis_anquilosante_6/evaluacion.php
Servicio de Rhumatologie, universitaire hopital Reina Sofía, departamento de Médecine,
Université de Cordoue, Córdoba, España. Joint Bone Spine (factor de impacto:
2,75). 02/2000; 67 (6): 516-20.Fuente: PubMed
HLA-B27, arthritis and spondylitis in an isolated community in Papua New Guinea. Br J
Rheumatol. 1990 Apr;29(2):97-100. González-Rodríguez M y cols. 2013 mexico
Sociedad Española de Reumatologia Guias Espondiloartritis 2009 Ariza-Ariza
R, Hernandez-Cruz B, Navarro-Sarabia F.
Physical function and health-related quality of life of Spanish patients with ankylosing
spondylitis. Arthritis
Rheum. 2003 Aug 15;49(4):483-7.
REFERENCES
101. Manifestaciones extraarticulares y complicaciones de la espondiloartritis anquilosante J.
Gratacós Unidad de Reumatología. Hospital de Sabadell. Institut Universitari ParcTaulí.
Universidad Autónoma de Barcelona. Sabadell. Barcelona España. 2009.
Mecanismos de la enfermedad: la inmunopatogénesis de espondiloartropatías Colina
Gaston Naturaleza de Práctica Clínica de Reumatología (2006) 2 , 383-392 doi : 10.1038 /
ncprheum0219
Las espondiloartropatias seronegativas: interacción entre la genética y el entorno
(entrevista). Documento Ciba-Geigy 1990;(4):5-7 .-The contribution of genes outside the
major histocompatibility complex to susceptibility to ankylosing spondylit
KELLEY REUMATOLOGIA CLINICA VII EDICION
Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history
for application as classification and diagnostic criteria. Ozgocmen S, Akgul O, Khan
MA. Mnemotécnico para la evaluación de los criterios de la sociedad internacional
espondiloartritis. J Rheumatol. 2010; 37 :. 1978
Osteoporosis and vertebral fractures in ankylosing spondylitis
Piet Geusensa,b, Debby Vossea and Sjef van der Lindena Current Opinion in
Rheumatology 2007, 19:335–339
Cardiovascular risks in spondyloarthritides
Sylvia Heeneman and Mat J.A.P. Daemen Current Opinion in Rheumatology 2007, 19:358–
362
REFERENCES
102. Classification criteria for spondyloarthropathies
Ozgur Akgul, Salih Ozgocmen, Division of Rheumatology, Department of
Physical Medicine and Rehabilitation, Erciyes University, Gevher Nesibe
Hospital, 38039 Kayseri,Turkey Author contributions: Akgul O and Ozgocmen
S collectively reviewed the literature and drafted the manuscript. 2011
December 18; 2(12): 107-115 Online Submissions:
http://www.wjgnet.com/2218-5836office
Diagnóstico precoz de espondiloartritis
Juan Mulero Mendoza
Servicio de Reumatología. Hospital Puerta de Hierro. Madrid. España.
Reumatol Clin. 2007;3 Supl 2:S15-8 15
Diagnostico precoz de las espondiloartropatı´as en Espan˜a: el programa
ESPeranza
Cristina Ferna´ndez Carballido, en nombre del Grupo ESPeranza
Hospital General de Elda, Alicante, Espan˜a 1699-258X/$ - see front matter &
2009 Elsevier Espan˜ a, S.L.Todos los derechos reservados.
doi:10.1016/j.reuma.2009.12.005 www.reumatologiaclinica.org
REFERENCES
104. Assessment and treatment of ankylosing spondylitis: current status and future directions Jane Zochling Current Opinion in Rheumatology 2008, 20:398–403
Assessment and treatment of ankylosing spondylitis: current status and future directions. Jane Zochling Current Opinion in Rheumatology 2008, 20:398–403
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M Rudwaleit,1 D van der Heijde,2 R Landewe´,3 J Listing,4 N Akkoc,5 J Brandt,6
J Braun,7 C T Chou,8 E Collantes-Estevez,9 M Dougados,10 F Huang,11 J Gu,12
M A Khan,13 Y Kirazli,14 W P Maksymowych,15 H Mielants,16 I J Sørensen,17
S Ozgocmen,18 E Roussou,19 R Valle-On˜ate,20 U Weber,21 J Wei,22 J Sieper1,23
Ann Rheum Dis 2009;68:777–783. doi:10.1136/ard.2009.108233
http://ard.bmj.com/
MRI in ankylosing spondylitis
Walter P. Maksymowych Current Opinion in Rheumatology 2009,21:313–317
Radiografı´a convencional: BASRI total y SASSS
Isabel Castrejo´n Ferna´ndez a,_ y Jesu´ s Sanz Sanz b a Servicio de Reumatologı´a, Hospital Universitario La Princesa, Madrid, Espan˜a b Servicio de Reumatologı´a, Hospital
Universitario Puerta de Hierro, Majadahonda, Madrid, Espan˜a 1699-258X/$ - see front matter & 2009 Elsevier Espan˜ a, S.L. Todos los derechos reservados.
doi:10.1016/j.reuma.2009.12.003
New therapeutic approaches for spondyloarthritis
Augustine M. Manadana, Neena Jamesb and Joel A. Block Curr Opin Rheumatol 19:259–264. _ 2007 Lippincott Williams & Wilkins.
aJohn H. Stroger Hospital of Cook County and Rush University Medical Center,
Chicago, Illinois, USA, bRush University Medical Center, Chicago, Illinois, USA and
cSection of Rheumatology, Rush University Medical Center, Chicago, Illinois, USA
Management and treatment of ankylosing spondylitis
Jane Zochling and Ju¨ rgen Braun Curr Opin Rheumatol 17:418—425. ª 2005 Lippincott Williams & Wilkins.
Rheumazentrum-Ruhrgebiet, St.Josefs-Krankenhaus, Landgrafenstr. 15, 44652
Herne, Germany
Rehabilitation in ankylosing spondylitis
Francine Ton Nghiem and John Patrick Donohue Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA
Correspondence to Francine Ton Nghiem, Beth Israel
Deaconess Medical Center, 330 Brookline Ave.,
Boston, MA 02215, USA
Current Opinion in Rheumatology 2008, 20:203–207
REFERENCES